PDF herunterladen
Aktuelle Dermatologie 2004; 30(10): 393-399
DOI: 10.1055/s-2004-825945
Jubiläum
© Georg Thieme Verlag KG Stuttgart · New York

30 Jahre Venerologie: 1974 - 2004 (ohne HIV-Infektionen)

30 Years of Venerology: 1974 - 2004 (without HIV-Infections)A.  Eichmann1
  • 1Spital Zollikerberg, Schweiz
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. Oktober 2004 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Zusammenfassung

Die Venerologie der letzten 30 Jahre wurde von der AIDS-Pandemie geprägt. Im Gefolge der AIDS-Prävention wurde weltweit ein Rückgang der venerischen Infektionen beobachtet. Im letzten Jahrzehnt kam es zu erneutem Anstieg der Syphilisinzidenz, vorerst in Osteuropa, dann auch im übrigen Europa. In der Syphilisdiagnostik wurden neue spezifische IgM-Tests eingeführt. Vor rund 30 Jahren begann die weltweite Ausbreitung der penizillinresistenten Gonokokkenstämme. Hochspezifische PCR-Tests für Gonokokken, Chlamydia trachomatis, Herpes simplex und Haemophilus ducreyi, wurden eingeführt. Bei den humanen Papillomviren wurden immer neue Serotypen entdeckt. Derzeit sind es schon über 100. Eine enge Assoziation bestimmter HPV-Typen mit intraepithelialen Neoplasien der Genitalregion, sowie mit invasiven ano-genitalen Carcinomen wurde erkannt. In der Therapie weckte Azithromycin, das gegen verschiedene STD-Erreger wirkt und die perorale Scabiesbehandlung mit Ivermectin, neue Hoffnungen.

Abstract

The veneral diseases of the last 30 years were strongly influenced by the AIDS-pandemic. As a result of AIDS-prevention a worldwide decrease of veneral infections was observed. A new increase of incidence in syphilis happened in the last decade; first of all in Eastern-European countries and later on everywhere in Europe. The specific IgM-tests were established in serology of syphilis. Thirty years ago the worldwide spread of penicilline-resistant strains of Gonococci started. Highly-specific PCR-tests were established for Gonoccoci, Chlamydia trachomatis, Herpes simplex virus and Haemophilus ducreyi. In the field of human papilloma-virus more and more new serotypes were discovered. Currently more than 100 serotypes are recognized. Certain specific HPV-types can induce the development of intraepithelial dysplasia and malignant epithelial tumors in the ano-genital area. Many new therapies have been established. Two of them should be mentioned: azithromycin, which is effective in many different infectious agents in STD, and Ivermectin, the first systemic agent against human scabies.

Literatur

  • 1 Pennisi E. Genome reveals wiles and weak points of syphilis.  Science. 1998;  281 (5375) 324-325
    CrossrefPubMedGoogle Scholar
  • 2 Radolf J D, Robinson E J, Bourell K W, Akins D R, Porcella S F, Weigel L M, Jones J D, Norgard M V. Characterization of outer membranes isolated from Treponema pallidum, the syphilis spirochete.  Infect Immun. 1995;  63 (11) 4244-4252
    PubMedGoogle Scholar
  • 3 Wicher K, Wicher V. Experimental syphilis in guinea pig.  Crit Rev Microbiol. 1989;  16 (3) 181-234
    PubMedGoogle Scholar
  • 4 Schell R F, Lefrock J L, Chan J K, Bagasra O. LSH hamster model of syphilitic infection.  Infect Immun. 1980;  28 (3) 909-913
    PubMedGoogle Scholar
  • 5 Schmidt B L. Solid-phase hemadsorption: a method for rapid detection of Treponema pallidum-specific IgM.  Sex Transm Dis. 1980;  7 (2) 53-58
    PubMedGoogle Scholar
  • 6 Müller F. Der 19S(IgM)-FTA-Abs-Test in der Serodiagnostik der Syphilis.  Infect Immun. 1982;  10 23
    PubMedGoogle Scholar
  • 7 Meyer J C. Laboratory diagnosis of syphilis.  Curr Probl Dermatol. 1996;  24 1-11
    PubMedGoogle Scholar
  • 8 Grimprel E, Sanchez P J, Wendel G D, Burstain J M, McCracken G H, Jr, Radolf J D, Norgard M V. Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid.  J Clin Microbiol. 1991;  29 (8) 1711-1718
    PubMedGoogle Scholar
  • 9 Hutchinson C M, Hook E W III, Shepherd M, Verley J, Rompalo A M. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection.  Ann Intern Med. 1994;  121 (2) 94-100
    PubMedGoogle Scholar
  • 10 IUSTI/WHO . 2001 European Guidelines for STD.  Int J STD and AIDS. 2001;  12 (Suppl 3)
    PubMedGoogle Scholar
  • 11 Tichonova L, Borisenko K, Ward H, Meheus A, Gromyko A, Renton A. Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control.  Lancet. 1997;  350 (9072) 210-213
    CrossrefPubMedGoogle Scholar
  • 12 Nicoll A, Hamers F F. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe?.  BMJ. 2002;  324 (7349) 1324-1327
    CrossrefPubMedGoogle Scholar
  • 13 Ashford W A, Golash R G, Hemming V G. Penicillinase-producing Neisseria gonorrhoeae.  Lancet. 1976;  2 (7987) 657-658
    PubMedGoogle Scholar
  • 14 Phillips J. Betalactamase-producing penicillin resistent gonococcus.  Lancet. 1976;  1 656-657
    PubMedGoogle Scholar
  • 15 Center for Disease Control, MMWR . Penicillinase-producing Neisseria gonorrhoeae, United States, worldwide.  MMWR. 1976;  38 8
    PubMedGoogle Scholar
  • 16 Eisenstein B I, Sox T, Biswas G, Blackman E, Sparling P F. Conjugal transfer of the gonococcal penicillinase plasmid.  Science. 1977;  195 (4282) 998-1000
    PubMedGoogle Scholar
  • 17 Mayer L W, Holmes K K, Falkow S. Characterization of plasmid deoxyribonucleic acid from Neisseria gonorrhoeae.  Infect Immun. 1974;  10 (4) 712-717
    PubMedGoogle Scholar
  • 18 Van Embden J D, van Klingeren B, Dessens-Kroon M, van Wijngaarden L J. Emergence in the Netherlands of penicillinase-producing gonococci carrying „Africa” plasmid in combination with transfer plasmid.  Lancet. 1981;  1 (8226) 938
    PubMedGoogle Scholar
  • 19 Hook E W, Hunter H H. Gonococcal infection in the adult. In: Holmes KK et al (eds) Sex Transm Dis 3rd ed. Mc Graw Hill 1999
    Google Scholar
  • 20 Mahony J B, Luinstra K E, Tyndall M, Sellors J W, Krepel J, Chernesky M. Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Genitourinary specimens.  J Clin Microbiol. 1995;  33 (11) 3049-3053
    PubMedGoogle Scholar
  • 21 Smith K R, Ching S, Lee H, Ohhashi Y, Hu H Y, Fisher H C III, Hook E W III. Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.  J Clin Microbiol. 1995;  33 (2) 455-457
    PubMedGoogle Scholar
  • 22 Handsfield H H, Lipman T O, Harnisch J P, Tronca E, Holmes K K. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance.  N Engl J Med. 1974;  290 (3) 117-123
    PubMedGoogle Scholar
  • 23 Stamm W E, Hicks C B, Martin D H, Leone P, Hook E W III, Cooper R H, Cohen M S, Batteiger B E, Workowski K, McCormack W M. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.  JAMA. 1995;  274 (7) 545-549
    CrossrefPubMedGoogle Scholar
  • 24 Habib A R, Fernando R. Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea.  Int I STD AIDS. 2004;  (4) 240-242
    PubMedGoogle Scholar
  • 25 Stehen R. Eradicating chancroid.  Bull World Health Organ. 2001;  79 (9) 818-826
    PubMedGoogle Scholar
  • 26 Nsanze H, Plummer F A, Maggwa A B, Maitha G, Dylewski J, P P iot, Ronald A R. Comparison of media for the primary isolation of Haemophilus ducreyi.  Sex Transm Dis. 1984;  11 (1) 6-9
    PubMedGoogle Scholar
  • 27 Lewis D A. Diagnostic tests for chancroid.  Sex Transm Infect. 2000;  76 (2) 137-141
    PubMedGoogle Scholar
  • 28 McNicol D APJ, Ronald A R. The plasmids of Haemophilus ducreyi.  J Antimicrob Chemother. 1984;  14 (6) 561-564
    PubMedGoogle Scholar
  • 29 Center for Disease Control and Prevention (CDC) . Sex Transm Dis Treatment guidelines 2002.  MMWR Recomm Rep. 2002;  51 RR-6
    PubMedGoogle Scholar
  • 30 Kellock D J, Barlow R, Suvarna S K, Green S, Eley A, Rogstad K E. Lymphogranuloma venereum: biopsy, serology, and molecular biology.  Genitourin Med. 1997;  73 (5) 399-401
    PubMedGoogle Scholar
  • 31 Wang S P, Kuo C C, Barnes R C, Stephens R S, Grayston J T. Immunotyping of Chlamydia trachomatis with monoclonal antibodies.  J Infect Dis. 1985;  152 (4) 791-800
    PubMedGoogle Scholar
  • 32 Maddocks I, Anders E M, Dennis E. Donovanosis in Papua New Guinea.  Br J Vener Dis. 1976;  52 (3) 90-196
    PubMedGoogle Scholar
  • 33 O'Farrell N. Trends in reported cases of donovanosis in Durban, South Africa.  Genitourin Med. 1992;  68 (6) 366-369
    PubMedGoogle Scholar
  • 34 Sehgal V N, Prasad A L. Donovanosis. Current concepts.  Int J Dermatol. 1986;  25 (1) 8-16
    PubMedGoogle Scholar
  • 35 Anonymous . National guideline for the management of donovanosis (granuloma inguinale). Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).  Sex Transm Infect. 1999;  75 (Suppl 1) S38-S39
    PubMedGoogle Scholar
  • 36 Schachter J. Chlamydial infections (in three parts).  N Engl J Med. 1978;  298 428, 490, 540
    PubMedGoogle Scholar
  • 37 Stephens R S, Wagar E A, Schoolnik G K. High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.  J Exp Med. 1988;  167 (3) 817-831
    CrossrefPubMedGoogle Scholar
  • 38 Schachter J. et al .Chlamydia. In: Murray et al. (eds) Manual of Microbiology, 6th ed. 1995: 669-677
    Google Scholar
  • 39 Schachter J. et al . LCR to detect C.trachomatis.  Sex Transm Dis. 1996;  23 177-180
    PubMedGoogle Scholar
  • 40 Mahony J B, Luinstra K E, Sellors J W, Jang D, Chernesky M A. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men.  J Clin Microbiol. 1992;  30 (9) 2241-2245
    PubMedGoogle Scholar
  • 41 Taylor-Robinson D. Tests for infection with Chlamydia trachomatis.  Int J STD AIDS. 1996;  7 (1) 19-25
    PubMedGoogle Scholar
  • 42 Dalaker K, Gjonnaess H, Kvile G, Urnes A, Anestad G, Bergan T. Chlamydia trachomatis as a cause of acute perihepatitis associated with pelvic inflammatory disease.  Br J Vener Dis. 1981;  57 (1) 41-43
    PubMedGoogle Scholar
  • 43 Taylor-Robinson D. Genital mycoplasma infections.  Clin Lab Med. 1989;  9 (3) 501-523
    PubMedGoogle Scholar
  • 44 Horner P, Thomas B, Gilroy C B, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis.  Clin Infect Dis. 2001;  32 (7) 995-1003
    CrossrefPubMedGoogle Scholar
  • 45 Taylor-Robinson D, Horner P J. The role of Mycoplasma genitalium in non-gonococcal urethritis.  Sex Transm Infect. 2001;  77 (4) 229-231
    PubMedGoogle Scholar
  • 46 Taylor-Robinson D, Bebear C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections.  J Antimicrob Chemother. 1997;  40 (5) 622-630
    CrossrefPubMedGoogle Scholar
  • 47 Quinn T L, Kieger J N. Trichomonasis. In: Warren KS, Mahmond AAF (eds.) Tropical and geographic Medecine, 2nd ed. New York; Mc Graw-Hill 1990: 358
    Google Scholar
  • 48 Honigberg B M. Trichomonas parasitic in Humans. London; Springer-Verlag 1989: 424
    Google Scholar
  • 49 Willcox R R. Epidemiological aspects of human trichomoniasis.  Br J Vener Dis. 1960;  36 167-174
    PubMedGoogle Scholar
  • 50 Krieger J N. Trichomoniasis in men: old issues and new data.  Sex Transm Dis. 1995;  22 (2) 83-96
    PubMedGoogle Scholar
  • 51 Gardner J. et al . Trichomonas vaginalis in the prostate gland.  Arch Pathol Lab Med. 1986;  110 430
    PubMedGoogle Scholar
  • 52 Hager W D, Brown S T, Kraus S J, Kleris G S, Perkins G J, Henderson M. Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens.  JAMA. 1980;  244 (11) 1219-1220
    CrossrefPubMedGoogle Scholar
  • 53 Sohn N, Robilotti J G, Jr. The gay bowel syndrome. A review of colonic and rectal conditions in 200 male homosexuals.  Am J Gastroenterol. 1977;  67 (5) 478-484
    PubMedGoogle Scholar
  • 54 Nahmias A J, Dowdle W R. Antigenic and biologic differences in herpesvirus hominis.  Prog Med Virol. 1968;  10 110-159
    PubMedGoogle Scholar
  • 55 Dolan A, Jamieson F E, Cunningham C, Barnett B C, McGeoch D J. The genome sequence of herpes simplex virus type 2.  J Virol. 1998;  72 (3) 2010-2021
    PubMedGoogle Scholar
  • 56 Ashley R L. Laboratory techniques in the diagnosis of herpes simplex infection.  Genitourin Med. 1993;  69 (3) 174-183
    PubMedGoogle Scholar
  • 57 Thin R N. Diagnosis of genital herpes simplex infections.  Curr Probl Dermatol. 1996;  24 50-56
    PubMedGoogle Scholar
  • 58 Groen J, van Dijk G, Niesters H G, Van Der Meijden W I, Osterhaus A D. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum.  J Clin Microbiol. 1998;  36 (3) 845-847
    PubMedGoogle Scholar
  • 59 Wald A, Zeh J, Selke S, Ashley R L, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections.  N Engl J Med. 1995;  333 (12) 770-775
    CrossrefPubMedGoogle Scholar
  • 60 Bryson Y J, Dillon M, Lovett M, Acuna G, Taylor S, Cherry J D, Johnson B L, Wiesmeier E, Growdon W, Creagh-Kirk T, Keeney R. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.  N Engl J Med. 1983;  308 (16) 916-921
    CrossrefPubMedGoogle Scholar
  • 61 Corey L, Nahmias A J, Guinan M E, Benedetti J K, Critchlow C W, Holmes K K. A trial of topical acyclovir in genital herpes simplex virus infections.  N Engl J Med. 1982;  306 (22) 1313-1319
    PubMedGoogle Scholar
  • 62 Douglas J M, Critchlow C, Benedetti J, Mertz G J, Connor J D, Hintz M A, Fahnlander A, Remington M, Winter C, Corey L. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.  N Engl J Med. 1984;  310 (24) 1551-1556
    PubMedGoogle Scholar
  • 63 Rockley P. et al . Valaciclovir for the treatment of recurrent genital HSV-infection.  Clin Res. 1993;  41 778A
    PubMedGoogle Scholar
  • 64 Straus S E, Wald A, Kost R G, McKenzie R, Langenberg A G, Hohman P, Lekstrom J, Cox E, Nakamura M, Sekulovich R, Izu A, Dekker C, Corey L. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial.  J Infect Dis. 1997;  176 (5) 1129-1134
    CrossrefPubMedGoogle Scholar
  • 65 Greenspan J S, Greenspan D. Oral hairy leukoplekia: Diagnosis and management.  Oral Surg Oral Med Oral Path. 1989;  67 396-403
    PubMedGoogle Scholar
  • 66 Syrjanen S, Laine P, Niemela M, Happonen R P. Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general.  J Oral Pathol Med. 1989;  18 (1) 8-31
    PubMedGoogle Scholar
  • 67 de Villiers E M. Papillomavirus and HPV typing.  Clin Dermatol. 1997;  15 (2) 199-206
    PubMedGoogle Scholar
  • 68 zur Hausen H. Papillomavirus infections - a major cause of human cancers.  Biochim Biophys Acta. 1996;  1288 (2) F55-F78
    PubMedGoogle Scholar
  • 69 Koutsky L. Epidemiology of genital human papillomavirus infection.  Am J Med. 1997;  102 (5A) 3-8
    PubMedGoogle Scholar
  • 70 Frisch M, Glimelius B, van den Brule A I, Wohlfahrt J, Meijer C J, Walboomers J M, Goldman S, Svensson C, Adami H O, Melbye M. Sexually transmitted infection as a cause of anal cancer.  Ugeskr Laeger. 1998;  160 (49) 7109-7117
    PubMedGoogle Scholar
  • 71 Walboomers J M, Jacobs M V, Manos M M, Bosch F X, Kummer J A, Shah K V, Snijders P J, Peto J, Meijer C J, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.  J Pathol. 1999;  189 (1) 12-19
    Google Scholar
  • 72 zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application.  Nat Rev Cancer. 2002;  2 (5) 342-350
    Google Scholar
  • 73 Rüdlinger R, Norval M. Human Papilloma Infections. In: Elsner P, Eichmann A (eds) Sex. Transm. Dis. Advances in Diagnosis and Treatment. Basel; Curr Probl Derm, Karger 1996: 67-76
    Google Scholar
  • 74 Wikstrom A, von Krogh G, Hedblad M A, Syrjanen S. Papillomavirus-associated balanoposthitis.  Genitourin Med. 1994;  70 (3) 175-181
    PubMedGoogle Scholar
  • 75 Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, Rylander E, Wadell G. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.  Sex Transm Dis. 1995;  22 (2) 119-127
    PubMedGoogle Scholar
  • 76 Gross G. Human papillomaviruses.  Ther Umsch. 2003;  60 (10) 595-604
    PubMedGoogle Scholar
  • 77 Edwards L, Ferenczy A, Eron L, Baker D, Owens M L, Fox T L, Hougham A J, Schmitt K A. Self-administered topical 5 % imiquimod cream for external anogenital warts. HPV Study Group: Human Papilloma Virus.  Arch Dermatol. 1998;  134 (1) 25-30
    PubMedGoogle Scholar
  • 78 Martin-Hirsch P. et al . photodynamic treatment for lower genital tract intra-epithelial neoplasia.  Lancet. 1998;  351 1403
    CrossrefPubMedGoogle Scholar
  • 79 DaSilva D M, Eiben G L, Fausch S C, Wakabayashi M T, Rudolf M P, Velders M P, Kast W M. Cervical cancer vaccines: emerging concepts and developments.  J Cell Physiol. 2001;  186 (2) 169-182
    CrossrefPubMedGoogle Scholar
  • 80 Smuness W. et al . On the role of sexual behaviour in the spread of hepatitis B infection.  Ann Intern Med. 1975;  13 489
    PubMedGoogle Scholar
  • 81 Esteban R. Epidemiology of hepatitis C virus infection.  J Hepatol. 1993;  17 (Suppl 3) S67-S71
    CrossrefPubMedGoogle Scholar
  • 82 Schwartz J J, Myskowski P L. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients.  J Am Acad Dermatol. 1992;  27 (4) 583-588
    PubMedGoogle Scholar
  • 83 Orkin M. Scabies in AIDS.  Semin Dermatol. 1993;  12 (1) 9-14
    PubMedGoogle Scholar
  • 84 Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei.  Arch Dermatol. 1997;  133 (6) 751-753
    CrossrefPubMedGoogle Scholar
  • 85 Walker G JA, Johnstone P W. Interventions for treating scabies (Cochrane Review).  The Cocherane Library. 2001;  Issue 3
    PubMedGoogle Scholar
  • 86 Victoria J, Trujillo R. Topical ivermectin: a new successful treatment for scabies.  Pediatr Dermatol. 2001;  18 (1) 63-65
    CrossrefPubMedGoogle Scholar

Prof. Dr. med. Alfred Eichmann

Spital Zollikerberg

Trichtenhauserstraße 20 · 8125 Zollikerberg · Schweiz

eMail: prof.eichmann@spitalzollikerberg.ch

      >